Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3256978 | Clinical Immunology | 2013 | 11 Pages |
It is unclear what roles TNF-α has in the development of autoimmune hepatitis (AIH) and whether AIH is responsive to anti-TNF-α. We recently developed a mouse model of fatal AIH that develops in PD-1-deficient mice thymectomized three days after birth, finding that CCR6-CCL20 axis-dependent migration of dysregulated splenic T cells is crucial to induce AIH. In this study, we show the indispensable role of TNF-α in the development of AIH. Administering anti-TNF-α prevented the induction, but treatment by anti-TNF-α after the induction did not suppress progression. Administering anti-TNF-α did not prevent splenic T-cell activation, but did suppress hepatic CCL20 expression. In contrast, administering anti-CCL20 suppressed AIH but not elevated serum TNF-α levels. TNF-α stimulation enhanced CCL20 expression in hepatocytes. These findings suggest that TNF-α is essential in the induction of AIH through upregulation of hepatic CCL20 expression, which allows migration of dysregulated splenic T cells.
► It is unclear what roles proinflammatory TNF-α has in the development of AIH. ► It is unknown whether AIH is responsive to TNF-α antagonists. ► Anti–TNF-α suppressed hepatic CCL20 expression and prevented induction of AIH. ► Anti–TNF-α treatment did not significantly suppress progression of fatal AIH. ► TNF-α is essential in the induction of AIH thorough upregulation of hepatic CCL20 expression.